Latest News

Promising chronic pain drug developed

A recent report indicates that 116-million Americans live with some form of chronic pain. Historically, chemists have developed drugs aimed at just one biological target. Two drugs used together may metabolize differently or present other issues. This new drug, named UMB 425 affects two different opioid receptors, providing diminished tolerance.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Commonly available blood-pressure medication prevents epilepsy after severe brain injury

  • Critical new protein complex involved in learning, memory

  • Teachers' scare tactics may lead to lower exam scores

  • Financial incentives help economically-disadvantaged pregnant smokers quit, improve fetal growth

  • Regulating legal marijuana could be guided by lessons from alcohol, tobacco, study says

  • Want to quit smoking? New study says try 'self-expanding' activities

  • Mentor programs harm, more than help first-year teachers

  • Physicists push new Parkinson's treatment toward clinical trials

  • First brain images of African infants enable research into cognitive effects of nutrition

  • New way to enhance nerve growth following injury discovered

  •